BCA
RMTI icon

Benchmark Capital Advisors’s Rockwell Medical RMTI Stock Holding History

Benchmark Capital Advisors’s Portfolio RMTI Stock Details RMTI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-95
Closed -$61K – 138
2017
Q4 		$61K Sell
95
-109
-53% -$76.8K 0.05% 135
2017
Q3 		$192K Sell
204
-4
-2% -$3.06K 0.15% 124
2017
Q2 		$182K Sell
208
-5
-2% -$4.1K 0.14% 119
2017
Q1 		$146K Sell
213
-6
-3% -$3.95K 0.12% 108
2016
Q4 		$158K Sell
219
-36
-14% -$24.9K 0.13% 110
2016
Q3 		$188K Hold
255
– – 0.14% 112
2016
Q2 		$212K Sell
255
-21
-8% -$19.5K 0.17% 109
2016
Q1 		$228K Sell
276
-19
-6% -$14.9K 0.2% 99
2015
Q4 		$332K Buy
+295
New +$343K 0.28% 76

Other funds holding RMTI

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
PCM
Perkins Capital Management Wayzata, Minnesota $107M AUM 82.62% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BA
BKS Advisors Southfield, Michigan $249M AUM 14.37% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
PCM
Perritt Capital Management Chicago, Illinois $59.8M AUM 26.94% 1-Year Est. Return

Benchmark Capital Advisors's RMTI Position: Q1 2018 in Review

Benchmark Capital Advisors sold out of Rockwell Medical (RMTI) in Q1 2018, closing a stake of 95 shares — an estimated $61K sold.

Benchmark Capital Advisors first reported a position in RMTI in Q4 2015 and held it in 9 quarters. The position peaked at $332K in Q4 2015. 84 funds tracked by Wall St. Rank hold RMTI as of Q1 2018.

  • Benchmark Capital Advisors reported no remaining Rockwell Medical position as of Q1 2018 after selling out during the quarter.
  • Benchmark Capital Advisors sold 95 Rockwell Medical shares in Q1 2018, an estimated $61K.
  • Benchmark Capital Advisors first reported a position in Rockwell Medical in Q4 2015 and held it in 9 quarters.
  • Benchmark Capital Advisors's Rockwell Medical position peaked at $332K in Q4 2015.
  • 84 funds tracked by Wall St. Rank held Rockwell Medical as of Q1 2018.

Based on Benchmark Capital Advisors's 13F filing for Q1 2018, filed 8 May 2018.